Trading Day: PPI surprise clips doves' wings
ORLANDO, Florida (Reuters) -TRADING DAY
Making sense of the forces driving global markets
By Jamie McGeever, Markets Columnist
A surprise spike in U.S. producer price inflation took the wind out of stock markets' sails on Thursday and prompted investors to reassess their view that an interest rate cut next month was a near certainty.
More on that below. In my column today I look at five charts that show the foundations underpinning the U.S. economy and Wall Street may be shakier if you strip out the AI- and tech-related spending.
If you have more time to read, here are a few articles I recommend to help you make sense of what happened in markets today.
1. Trump's data war risks creating false calm: Mike Dolan 2. Fed hawks and doves: what U.S. central bankers aresaying 3. Trump's debanking order could create headaches forbanks, sources say 4. Trump says Putin ready to make deal on Ukraine, U.S.hopes to include Zelenskiy 5. Which Donald Trump will negotiate with Putin in Alaska?
Today's Key Market Moves
* STOCKS: The Russell 2000 falls 1.3% but the S&P 500,Nasdaq and Dow basically end flat. Indeed, the S&P 500 manages anew closing high. * SHARES/SECTORS: Seven sectors in the S&P 500 fall, ledby industrials and materials, off around 0.9%. Fashion retailerTapestry sinks 15% on tariff, profit warning. * FX: Dollar rebounds around 0.5% for its best day in twoweeks. Biggest G10 FX move is New Zealand dollar, down 1%. * BONDS: Treasury yields rise as much as 5 bps. Curvesbarely move, but 2s/30s still close to steepest levels in threeyears around 115 bps. * COMMODITIES: Oil spikes around 2%, its biggest rise intwo weeks.
Today's Talking Points:
* The Fed outlook. Rates traders trimmed the probability of a quarter-point rate cut next month to 90% from 100% after the release of July's producer price inflation data. Core annual PPI shot up to 3.7%, the highest in three years. Excluding pandemic distortions, the jump from June's 2.6% was the biggest since comparable data was first gathered in 2011.
Talk of a 50-basis point cut next month, partly fueled by Treasury Secretary Scott Bessent on Wednesday, has evaporated. The PPI data ensured that, but Bessent also rowed back a bit on Thursday. Another couple of solid inflation and employment reports, and could a September cut be taken off the table completely?
* European GDP. The first estimate of Q2 UK growth was released on Thursday and broadly speaking, the 0.3% expansion was better than expected - or not as bad as feared, depending on your view. Indeed, Britain's economy grew nearly twice as fast as the U.S. economy in the first half of the year.
Euro zone GDP was less stellar, with a slump in industrial production in June and downward revision to May capping overall GDP growth in the April-June period at just 0.1%. That marked a clear slowdown from 0.6% expansion in the first quarter.
The elephant in the room, of course, is the impact of tariffs, which has yet to be fully felt, suggesting the second half of the year is likely to be bumpier than the first.
* Do you want to make a deal? Donald Trump and Vladimir Putin meet in Alaska on Friday, with the U.S. President saying his Russian counterpart is keen to "make a deal" on Ukraine. The aim of Friday's talks is to set up a second meeting including Ukraine, and perhaps agree the framework for a ceasefire.
Despite his harsher tone toward Putin over the past months, Trump has a long history of trying to placate the Russian leader. The Trump administration has sought to temper expectations, and White House press secretary Karoline Leavitt told reporters on Tuesday the meeting would be a "listening exercise."
That's probably not what Ukrainian President Volodymyr Zelenskiy wants to hear.
The U.S. economy's key weak spots in five charts
The U.S. economy seems to be chugging along fairly smoothly, if a little too slowly for some observers' liking. Under the bonnet, however, the picture is more worrisome, and the risk of engine malfunction is rising.
Technology's role in the U.S. economy has never been greater, and artificial intelligence could deliver a historic productivity boom. But return on the huge investment being made on that bet could take years to materialize. What's more, an unbalanced economy may not be desirable in the long term, as it can lead to poor investment and policy decisions.
Below are five charts that indicate the foundations of the resilient U.S. economy and booming stock market may be much shakier than they appear, especially if AI- and tech-related spending, investment and optimism are stripped out.
INVESTMENT
Inflation-adjusted investment in 'AI-sensitive' sectors of the economy since the end of 2019 has risen 53%, notes Troy Ludtka, senior U.S. economist at SMBC Nikko Securities. Investment elsewhere has inched up just 0.3%.
CONTRIBUTION TO GDP
Relatedly, the contribution of software and IT equipment capex to U.S. GDP has never been higher, according to analysts at BlackRock. Aggregate capex in all other areas of the economy, however, actually fell in the first half of this year – a rare occurrence.
CONSUMER SPENDING
Meanwhile, personal consumption expenditures are slowing sharply, a worrying sign given that the consumer accounts for around 70% of total U.S. GDP. Personal consumption expenditures in the second quarter grew by only 0.9%, the slowest pace since the pandemic. And in real terms, consumer spending has completely flat-lined in the first half of the year.
CORPORATE BANKRUPTCIES
Corporate bankruptcies in July were the highest for a single month since July 2020, according to S&P Global Market Intelligence. Even more alarming, the tally of year-to-date bankruptcy filings through the end of July was the highest for this seven-month period since 2010. Nearly a third of this year's bankruptcies were in the consumer discretionary and industrial sectors.
STOCK MARKET CONCENTRATION
Finally, the concentration on Wall Street has been widely discussed, but the levels continue to be eye-popping. One stock, chipmaker Nvidia, accounts for 8% of the benchmark S&P 500's entire market cap. That's a record for a single name.
And the top 10 stocks, most of which are Big Tech megacaps, make up 40% of the index's market cap and 30% of all earnings. These are also record levels.
The more Wall Street – and even global markets - rely on the revenue, earnings and profitability of a set of companies that can be counted on two hands, the bigger the potential mess could be if the trends driving these companies' performance lose momentum.
What could move markets tomorrow?
* China "data dump" including investment, retail sales,industrial production, house prices, unemployment (July) * Japan GDP (Q2) * Taiwan GDP (Q2, revised) * Hong Kong GDP (Q2, final) * U.S. retail sales (July) * U.S. industrial production (July) * U.S. New York Fed manufacturing (July) * U.S. University of Michigan inflation expectations andconsumer sentiment (August, prelim) * U.S. President Donald Trump and Russian President VladimirPutin summit in Anchorage, Alaska.
Want to receive Trading Day in your inbox every weekday morning? Sign up for my newsletter here.
Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
(By Jamie McGeever; Editing by Nia Williams)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
27 minutes ago
- Yahoo
Flowers Foods Inc (FLO) Q2 2025 Earnings Call Highlights: Navigating Market Shifts with ...
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Flowers Foods Inc (NYSE:FLO) is aggressively transitioning its portfolio to align with current consumer demand, which is expected to drive long-term growth. The company has seen success with its differentiated products, such as Dave's Killer Bread and Canyon Bakehouse, which are performing well in the market. Flowers Foods Inc (NYSE:FLO) is actively innovating, with new products like small loaves and keto offerings showing promising growth. The company is experiencing substantial space gains in mass channels for its organic products, particularly Dave's Killer Bread, indicating strong market acceptance. Despite challenges, Flowers Foods Inc (NYSE:FLO) maintains a strong market share performance, particularly in premium and differentiated product segments. Negative Points The company is facing increased competitive pressure, particularly from new lower-priced bread products affecting traditional loaf sales. There is ongoing weakness in the away-from-home food service business, impacting overall performance. Flowers Foods Inc (NYSE:FLO) has reduced its EPS guidance, narrowing the gap between dividend commitments and current EPS run rate. The transition to align with shifting consumer trends is expected to take time, requiring patience from stakeholders. The company is experiencing negative fixed cost leverage due to lower volumes, impacting gross margins. Q & A Highlights Warning! GuruFocus has detected 6 Warning Sign with FLO. Q: Ryals, can you provide more details on the competitive environment and the impact of new lower-priced bread products? A: The promotional environment is elevated but stable. We've increased promotions, especially for differentiated products like Dave's Killer Bread (DKB), which performed well. Lower-priced entrants are affecting traditional loaf areas, but we're addressing this with our own small loaves. The market remains bifurcated, with good performance in premium and value segments, particularly in mass and club channels. We're also seeing continued weakness in the away-from-home food service business. Q: Steve, regarding the updated tariff outlook, have previous tariff costs been delayed or structurally updated? Also, how does the reduction in EPS guidance affect capital allocation, especially concerning dividends? A: The tariff update is structural, with expectations for tariffs to decrease based on current observations. Regarding capital allocation, we maintain a balanced approach, and the board evaluates performance, cash flow, and liquidity quarterly. We don't have a stated target payout ratio, but on a cash basis, it's different due to depreciation and amortization being above CapEx. Q: Are we returning to a highly competitive environment similar to years ago, with aggressive pricing strategies? A: The category is transitioning due to shifting consumer trends, such as health and wellness and ultra-processed food concerns. We're committed to innovation to navigate this transition. Traditional loaf products are most affected, but we're seeing success with differentiated products like DKB and Canyon Bakehouse. We have plans to address traditional loaf weaknesses, but I won't disclose details for competitive reasons. Q: Can you comment on the performance of Wonder and its impact on Tastykake? A: Wonder's launch has exceeded expectations without cannibalizing Tastykake, likely due to geographic strengths. Wonder is a national brand, while Tastykake is strong in the mid-Atlantic. We're pleased with Wonder's performance and have more innovation planned. Q: How long will the transition take, and are there near-term solutions to speed it up? A: The transition will take time, but I won't specify a duration. The category will stabilize eventually, driven by consumer behavior shifts and the pandemic's final effects. Our focus is on innovation to replace declines in traditional loaf sales. We have the number one brand and SKU, and we'll continue investing in brands like Nature Zone to mitigate losses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.